AI Therapeutics is Drug Discovery in United States that focus on rare diseases business. Founded in 2013. They cover business area such as developer, precision therapeutic technology, cancer, rare disease, drug development, next-gen sequencing, genome editing, chemical genomic, combinational drug screening, deep learning, clinical drug, doctor, significant therapeutic benefit, patient.
2013
( 11 years old in 2024 )
Rare Diseases
-
530 Old Whitfield Street
Guilford, CT 06437
United States
Private
developerprecision therapeutic technologycancerrare diseasedrug developmentnext-gen sequencinggenome editingchemical genomiccombinational drug screeningdeep learningclinical drugdoctorsignificant therapeutic benefitpatient
* We use standard office opening hours in near AI Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AI Therapeutics is Drug Discovery business from United States that founded in 2013 (11 years old in 2024), AI Therapeutics business is focusing on Rare Diseases.
AI Therapeutics headquarter office and corporate office address is located in 530 Old Whitfield Street Guilford, CT 06437 United States.
AI Therapeutics was founded in United States.
In 2024, AI Therapeutics is currently focus on rare diseases sector.
Above is snippet of Google Trends for "rare diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AI Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.